A final rule takes effect October 13 barring federal Medicaid and CHIP payment for a service line more than a dozen tracked health centers advertise — and the age cutoff is different in Medicaid than in CHIP

CMS-2451-F (RIN 0938-AV73) published August 13, 2026 at 91 FR 52406-52474 and is EFFECTIVE OCTOBER 13, 2026. It adds a new subpart N to 42 CFR part 441 and a new Sec. 457.476, and it was signed by Robert F. Kennedy, Jr., Secretary of Health and Human Services.

WHAT IT REQUIRES, verbatim from Sec. 441.802: “a State plan must provide that the Medicaid agency will not make payment under the plan for sex-rejecting procedures for children under the age of 18,” and “FFP is not available in State expenditures” for those procedures. 🔑 THE OPERATIONAL TRAP IS THE AGE, AND IT IS NOT THE SAME NUMBER TWICE.

Medicaid is under 18. Separate CHIP is under 19, because Sec. 457.476 ties it to the targeted low-income child definition at Sec. 457.310, and it applies “regardless of the type of health benefit coverage option described at Sec. 457.410.”

A billing or eligibility workflow built on one threshold will be wrong for the other program. THE TAPER IS NARROWER THAN IT SOUNDS. Sec. 441.802(c) keeps FFP available for cross-sex hormone therapy “for a tapering period of up to 6 months from October 13, 2026, for beneficiaries who were receiving such therapy as of October 13, 2026.”

Two limits are load-bearing: it covers hormone therapy only, and only patients already on therapy ON that date — a start after October 13 is not inside the taper. The window therefore runs to roughly April 13, 2027.

THREE EXCLUSIONS SIT IN THE DEFINITION ITSELF at Sec. 441.801(3), and the third is the one clinicians will need most: the term does not include procedures undertaken “to treat an individual with a medically verifiable disorder of sexual development,” or “for purposes other than attempting to align an individual’s physical appearance or body with an asserted identity that differs from the individual’s sex,” or “to treat complications, including any infection, injury, disease, or disorder that has been caused by or exacerbated by the performance of sex-rejecting procedure(s).”

Complications care remains payable. THE RULE DOES NOT NAME FQHCs AS A REGULATED PARTY. The obligation runs to STATE Medicaid and CHIP agencies and to federal financial participation, so it reaches a health center by operation as a Medicaid or CHIP provider rather than by name.

Health centers turn up in the rule only inside CMS’s summary of public comments, where commenters argued the rule would be “especially financially harmful to rural hospitals and clinics, as well as Federally Qualified Health Centers and other safety net providers,” and that it “may place Federally Qualified Health Centers and Certified Community Behavioral Health Centers in conflict with State scope of practice laws.”

CMS did not agree. WHY IT LANDS HERE ANYWAY: gender-affirming care is a named program at multiple health centers in our own California directory, including Los Angeles LGBT Center, and a payment prohibition with a 36-day runway is a revenue-and-workflow question regardless of how the underlying policy is judged.

The rule publishes no patient count and no dollar figure. Implementation runs through each state plan, so confirm with your state Medicaid agency and your managed-care plans how your state operationalizes the prohibition, the age split, and the taper before changing a single workflow.